The Prognostic Role of Circulating Tumor Cells (CTC) in High-risk Non–muscle-invasive Bladder Cancer
作者： Gian Maria Busetto , Matteo Ferro , Francesco Del Giudice , Gabriele Antonini , Benjamin I. Chung
DOI: 10.1016/J.CLGC.2017.01.011
关键词:
摘要: … time to first recurrence (TFR), defined as the time between CTC identification and first local recurrence and time to progression (TTP), defined as the time between CTC identification and …
elsevier.com
core.ac.uk 
sci-hub.se 参考文章(23)
Michael Rink, Felix K.H. Chun, Sarah Minner, Martin Friedrich, Oliver Mauermann, Hans Heinzer, Hartwig Huland, Margit Fisch, Klaus Pantel, Sabine Riethdorf, Detection of circulating tumour cells in peripheral blood of patients with advanced non‐metastatic bladder cancer BJUI. ,vol. 107, pp. 1668- 1675 ,(2011) , 10.1111/J.1464-410X.2010.09562.X
Angela Gradilone, Arianna Petracca, Chiara Nicolazzo, Walter Gianni, Enrico Cortesi, Giuseppe Naso, Bruno Vincenzi, Cristiano Cristini, Ettore De Berardinis, Franco Di Silverio, Anna Maria Aglianò, Paola Gazzaniga, Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer. BJUI. ,vol. 106, pp. 710- 715 ,(2010) , 10.1111/J.1464-410X.2009.09130.X
Alexander Dobrovic, Jennifer E. Hardingham, Belinda Farmer, Dusan Kotasek, Jing-Xian Mi, Robert E. Sage, Ross N. Butler, Immunobead-PCR: A Technique for the Detection of Circulating Tumor Cells Using Immunomagnetic Beads and the Polymerase Chain Reaction Cancer Research. ,vol. 53, pp. 3455- 3458 ,(1993)
Francesca Sanguedolce, Antonella Cormio, Pantaleo Bufo, Giuseppe Carrieri, Luigi Cormio, Molecular markers in bladder cancer: Novel research frontiers. Critical Reviews in Clinical Laboratory Sciences. ,vol. 52, pp. 242- 255 ,(2015) , 10.3109/10408363.2015.1033610
Hyung Suk Kim, Myong Kim, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, Ja Hyeon Ku, Presence of lymphovascular invasion in urothelial bladder cancer specimens after transurethral resections correlates with risk of upstaging and survival: A systematic review and meta-analysis☆ Urologic Oncology-seminars and Original Investigations. ,vol. 32, pp. 1191- 1199 ,(2014) , 10.1016/J.UROLONC.2014.05.008
Richard J. Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, J. Alfred Witjes, Christian Bouffioux, Louis Denis, Donald W.W. Newling, Karlheinz Kurth, Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. European Urology. ,vol. 49, pp. 466- 477 ,(2006) , 10.1016/J.EURURO.2005.12.031
M Sakaguchi, A K Virmani, R Ashfaq, T E Rogers, A Rathi, Y Liu, D Kodagoda, H T Cunningham, A F Gazdar, Development of a sensitive, specific reverse transcriptase polymerase chain reaction-based assay for epithelial tumour cells in effusions. British Journal of Cancer. ,vol. 79, pp. 416- 422 ,(1999) , 10.1038/SJ.BJC.6690065
Michael Rink, Felix K. Chun, Roland Dahlem, Armin Soave, Sarah Minner, Jens Hansen, Malgorzata Stoupiec, Cornelia Coith, Luis A. Kluth, Sascha A. Ahyai, Martin G. Friedrich, Shahrokh F. Shariat, Margit Fisch, Klaus Pantel, Sabine Riethdorf, Prognostic Role and HER2 Expression of Circulating Tumor Cells in Peripheral Blood of Patients Prior to Radical Cystectomy: A Prospective Study European Urology. ,vol. 61, pp. 810- 817 ,(2012) , 10.1016/J.EURURO.2012.01.017
A. Orsola, I. Trias, C.X. Raventós, I. Español, L. Cecchini, S. Búcar, D. Salinas, I. Orsola, Initial High-Grade T1 Urothelial Cell Carcinoma: Feasibility and Prognostic Significance of Lamina Propria Invasion Microstaging (T1a/b/c) in BCG-Treated and BCG-Non-Treated Patients European Urology. ,vol. 48, pp. 231- 238 ,(2005) , 10.1016/J.EURURO.2005.04.013
Gary J. Kelloff, Caroline C. Sigman, Howard I. Scher, Biomarker development in the context of urologic cancers Urologic Oncology-seminars and Original Investigations. ,vol. 33, pp. 295- 301 ,(2015) , 10.1016/J.UROLONC.2015.01.007